Log In
Monday 28th May 2018

US withdraws migraine drugs

7th March 2007

The United States Food and Drug Administration (FDA) has ordered 15 unapproved migraine medications withdrawn from the market.


The drugs have in common the active ingredient ergotamine, and are unrelated to the triptan class of drugs commonly used to treat migraine.

FDA-approved ergotamine drugs are unaffected.

The 15 brands are being withdrawn because they lack a crucial 'black box' safety warning telling patients not to use such drugs if they are also taking certain medications that block an enzyme needed to break down and remove ergotamine from the body.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018